(MENAFN - iCrowdNewsWire) According to our new research study on ''Sleep Apnea Devices Market Forecast To 2025 –Global Analysis – by Diagnostic Devices, Therapeutic Devices, and End User,” the market is expected to reach US$ 8,305.3 million in 2025 from US$ 4,033.0 million in 2016; it is estimated to grow at a CAGR of 7.9% from 2016 to 2025. The report highlights trends prevailing in the market, and the factors driving and hindering the market growth. The growth of the global sleep apnea devices market is attributed to the technological advancements, rising geriatric population and the declining prices of sleep apnea devices are likely to have a positive impact on the growth of the market in the coming years. However, absence of patient compliance is the major factor hindering the market growth.
For sample report click:
Based on therapeutic devices, the global sleep apnea devices market is segmented into facial interfaces, adaptive servo- ventilation instruments (ASV), positive airway pressure (PAP) devices, oxygen concentrators, airway clearance systems, oral appliances, and accessories. The positive airway pressure segment held the largest market share in 2017, and the same segment is estimated to register the highest CAGR during the forecast period. Rising easy usage and handy nature offer lucrative opportunities for the growth of positive airway pressure segment.
The global sleep apnea devices market is impacted by the pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.
Braebon Medical Corporation, Compumedics Limited, BMC Medical Co., Ltd, Fisher & Paykel Healthcare Limited, ResMed, SomnoMed Limited, Weinmann Emergency Medical Technology, Devilbiss Healthcare LLC., Koninklijke Philips N.V. and Whole You, Inc. are among the leading companies operating in the global sleep apnea devices market.
Increased Usage of Oral Devices to Drive Global Sleep Apnea Devices Market Growth
Obstructive sleep apnea (OSA) is a normal and very common disorder which is categorized by the repetitive, complete or partial closure of the upper airway while sleep that is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes the significant morbidity, especially in terms of impairment of daytime functioning and the impact this has on quality of life. The recent indication from the controlled trials is the proof for the oral appliance therapy which is very effective in controlling OSA in up to 50.0% of patients, which includes some patient with more severe forms of OSA. This is associated with a significant improvement in symptoms, including snoring and daytime sleepiness. This evidence is strong for short term, and emerging for long-term treatment of OSA with oral appliances. Various companies have developed their products for the treatment of sleep apnea and the related accessories. For instance, SomnoDent devices developed by SomnoMed Limited, has increased in the previous year, 2016 from 68% to 68.6%, which signifies that the products have achieved on the signature-line of products. Additionally, SomnoDent Alpha has developed and received FDA approval in September 2016. The Alpha is an instant fit device, used in the sleep clinics for offering the patient and deliver efficacy data of a continuous open airway therapy (COAT) treatment relating to a specific patient before a device is custom made for the patient.
Owing to the rising usage of the oral devices in the various regions, the need and demand for the improved and advanced oral devices for the treatment of the OSA and it increases the market in the future years.
The report segments global sleep apnea devices market as follows:
By Diagnostic Devices
- Polysomnography Devices
- Respiratory Polygraphs
- Actigraphy systems
By Therapeutic Devices
- Facial Interfaces
- Adaptive Servo-Ventilation Instruments (ASV)
- Positive Airway Pressure (PAP) Devices
- Oxygen Concentrators
- Airway Clearance Systems
- Oral Appliances
By End User
- Home Healthcare
- Sleep Laboratories and Hospitals
- North America
- Rest of Europe
- Asia Pacific (APAC)
- South Korea
- Rest of APAC
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- Rest of MEA
- South and Central America (SCAM)
- Rest of SCAM
Interested in purchasing this Report? Click here to buy @
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.